Dr. Sandra Rebish
Dermatology · Upland, CA
CMS Profile ID: 147012 · NPI: 1235252289
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$562,112
Number of Payments
40
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Consulting Fee | $540,325 |
| Travel and Lodging | $20,748 |
| Food and Beverage | $1,038 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Incyte Corporation | $319,109 |
| UCB, Inc. | $238,108 |
| Janssen Scientific Affairs, LLC | $4,250 |
| Janssen Biotech, Inc. | $228 |
| Novartis Pharmaceuticals Corporation | $107 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $106 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?